Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria T Acosta

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Pediatric Neurology|April 12, 2012
Cognitive profiles of neurofibromatosis type 1 patients with minor brain malformationsMaria T Acosta, Karin S Walsh, Peter G Kardel, et al.
Birth Defects Research|October 19, 2019
Circle of Willis anomalies in Turner syndrome: Absent A1 segment of the anterior cerebral arteryPaul Kruszka, Ashley Buscetta, Maria T Acosta, et al.
Orphanet Journal of Rare Diseases|March 15, 2025
Retrospective assessment of clinical global impression of severity and change in GM1 gangliosidosis: a tool to score natural history data in rare disease cohortsConnor J Lewis, Jean M Johnston, Silvia Zaragoza Domingo, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Differential Tractography: A Biomarker for Neuronal Function in Neurodegenerative DiseaseConnor J Lewis, Zeynep Vardar, Anna Luisa Kühn, et al.
Innovations in Clinical Neuroscience|January 31, 2022
Clinician- and Patient-reported Endpoints in CNS Orphan Drug Clinical Trials: ISCTM Position Paper on Best Practices for Endpoint Selection, Validation, Training, and StandardizationJoan Busner, Gahan Pandina, SilviaZaragoza Domingo, et al.
Developmental Medicine and Child Neurology|August 21, 2020
Autism in neurofibromatosis type 1: misuse of covariance to dismiss autistic trait burdenStephanie M Morris, Maria T Acosta, Shruti Garg, et al.
Attention Deficit and Hyperactivity Disorders|September 27, 2012
Analysis of brain metabolism by proton magnetic resonance spectroscopy (1H-MRS) in attention-deficit/hyperactivity disorder suggests a generalized differential ontogenic pattern from controlsMauricio Arcos-Burgos, Ana C Londoño, David A Pineda, et al.
Neuroscience Letters|March 22, 2012
Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1Camille Chabernaud, Maarten Mennes, Peter G Kardel, et al.
Brain Communications|June 4, 2025
Differential tractography: an imaging marker for tissue degeneration in neurodegenerative diseasesConnor J Lewis, Zeynep Vardar, Anna Luisa Kühn, et al.
Human Genetics|June 22, 2026
Combined family-based association and linkage analyses in families affected by attention-deficit hyperactivity disorderCristina M Justice, Kwangmi Ahn, Benjamin Jung, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Pediatric Neurology|April 12, 2012
Cognitive profiles of neurofibromatosis type 1 patients with minor brain malformationsMaria T Acosta, Karin S Walsh, Peter G Kardel, et al.
Birth Defects Research|October 19, 2019
Circle of Willis anomalies in Turner syndrome: Absent A1 segment of the anterior cerebral arteryPaul Kruszka, Ashley Buscetta, Maria T Acosta, et al.
Orphanet Journal of Rare Diseases|March 15, 2025
Retrospective assessment of clinical global impression of severity and change in GM1 gangliosidosis: a tool to score natural history data in rare disease cohortsConnor J Lewis, Jean M Johnston, Silvia Zaragoza Domingo, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Differential Tractography: A Biomarker for Neuronal Function in Neurodegenerative DiseaseConnor J Lewis, Zeynep Vardar, Anna Luisa Kühn, et al.
Innovations in Clinical Neuroscience|January 31, 2022
Clinician- and Patient-reported Endpoints in CNS Orphan Drug Clinical Trials: ISCTM Position Paper on Best Practices for Endpoint Selection, Validation, Training, and StandardizationJoan Busner, Gahan Pandina, SilviaZaragoza Domingo, et al.
Developmental Medicine and Child Neurology|August 21, 2020
Autism in neurofibromatosis type 1: misuse of covariance to dismiss autistic trait burdenStephanie M Morris, Maria T Acosta, Shruti Garg, et al.
Attention Deficit and Hyperactivity Disorders|September 27, 2012
Analysis of brain metabolism by proton magnetic resonance spectroscopy (1H-MRS) in attention-deficit/hyperactivity disorder suggests a generalized differential ontogenic pattern from controlsMauricio Arcos-Burgos, Ana C Londoño, David A Pineda, et al.
Neuroscience Letters|March 22, 2012
Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1Camille Chabernaud, Maarten Mennes, Peter G Kardel, et al.
Brain Communications|June 4, 2025
Differential tractography: an imaging marker for tissue degeneration in neurodegenerative diseasesConnor J Lewis, Zeynep Vardar, Anna Luisa Kühn, et al.
Human Genetics|June 22, 2026
Combined family-based association and linkage analyses in families affected by attention-deficit hyperactivity disorderCristina M Justice, Kwangmi Ahn, Benjamin Jung, et al.
Pageof 8